Cargando…
Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids()()
Pancreatic cancer (PC) is a lethal disease which is characterized by chemoresistance. Components of the cell cytoskeleton are therapeutic targets in cancer. βIV-tubulin is one such component that has two isotypes—βIVa and βIVb. βIVa and βIVb isotypes only differ in two amino acids at their C-terminu...
Autores principales: | Sharbeen, G., McCarroll, J., Liu, J., Youkhana, J., Limbri, L.F., Biankin, A.V., Johns, A., Kavallaris, M., Goldstein, D., Phillips, P.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126129/ https://www.ncbi.nlm.nih.gov/pubmed/27889644 http://dx.doi.org/10.1016/j.neo.2016.10.011 |
Ejemplares similares
-
βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer
por: McCarroll, Joshua A., et al.
Publicado: (2014) -
Resistance to anti-tubulin agents: From vinca alkaloids to epothilones
por: Krause, Werner
Publicado: (2019) -
Metabolites of Vinca Alkaloid Vinblastine: Tubulin
Binding and Activation of Nausea-Associated Receptors
por: Chagas, Caroline Manto, et al.
Publicado: (2019) -
Structural convergence for tubulin binding of CPAP and vinca domain microtubule inhibitors
por: Campanacci, Valérie, et al.
Publicado: (2022) -
Vinca Alkaloids
por: Moudi, Maryam, et al.
Publicado: (2013)